@iebpharma
What is Tofacitinib 5 mg (Tofacent) approved for?
Tofacitinib, marketed under the brand name Xeljanz, is a Janus kinase (JAK) inhibitor that is approved by regulatory authorities such as the U.S. Food and Drug Administration (FDA) for the treatment of several autoimmune and inflammatory diseases. The drug works by selectively inhibiting JAK enzymes, which play a crucial role in the signaling pathways that […]
How long can I take olaparib?
Olaparib, a medication used to treat specific types of cancer, works by inhibiting cancer cell growth, specifically targeting tumors that are linked to defects in DNA repair mechanisms. The duration for taking olaparib depends on several factors, including the type of cancer being treated, the patient’s response to the medication, and any potential side effects […]
How much does osimertinib cost?
Osimertinib is a targeted therapy medication primarily used in the treatment of non-small cell lung cancer (NSCLC) harboring specific mutations in the epidermal growth factor receptor (EGFR). Its cost can vary based on factors such as brand, dosage, and regional pricing strategies. Below is a detailed overview of osimertinib, including its indications, pharmacology, dosage, side […]
What is the success rate of baricitinib?
Baricitinib is a medication primarily used to treat moderate to severe rheumatoid arthritis (RA), a chronic inflammatory condition that affects the joints. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. By inhibiting specific enzymes known as JAK1 and JAK2, Baricitinib disrupts the immune response that contributes to the inflammation and damage […]
What is Avalet 20 mg used for?
Avalet 20 mg is a pharmaceutical medication commonly prescribed to manage high blood pressure (hypertension) and various heart-related conditions. It belongs to a class of drugs known as angiotensin II receptor antagonists (ARBs), which work by blocking the action of angiotensin II. This is a hormone that constricts blood vessels and raises blood pressure. By […]
What is the new miracle drug for lung cancer?
Recent advancements in lung cancer treatment have led to the development of several innovative therapies that offer hope for improved patient outcomes. These treatments encompass novel drug combinations, targeted therapies, and immunotherapies, each designed to address specific genetic mutations and tumor characteristics. 1. Amivantamab and Osicent 80 mg (Osimertinib) Combination: A groundbreaking combination of amivantamab, […]